These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27133037)

  • 1. Utilization of nanoparticle technology in rheumatoid arthritis treatment.
    Dolati S; Sadreddini S; Rostamzadeh D; Ahmadi M; Jadidi-Niaragh F; Yousefi M
    Biomed Pharmacother; 2016 May; 80():30-41. PubMed ID: 27133037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing micro- and nano-particles for treating rheumatoid arthritis.
    Mitragotri S; Yoo JW
    Arch Pharm Res; 2011 Nov; 34(11):1887-97. PubMed ID: 22139688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment.
    Pirmardvand Chegini S; Varshosaz J; Taymouri S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):502-514. PubMed ID: 29661045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano - Based Therapeutic Strategies in Management of Rheumatoid Arthritis.
    Nautiyal G; Sharma SK; Kaushik D; Pandey P
    Recent Pat Nanotechnol; 2024; 18(4):433-456. PubMed ID: 37904559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic nanoparticles: A new diagnostic and treatment platform for rheumatoid arthritis.
    Liu Y; Cao F; Sun B; Bellanti JA; Zheng SG
    J Leukoc Biol; 2021 Feb; 109(2):415-424. PubMed ID: 32967052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancement in nanotechnology for treatment of rheumatoid arthritis: scope and potential applications.
    Rani R; Raina N; Sharma A; Kumar P; Tulli HS; Gupta M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2287-2310. PubMed ID: 37166463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Generation Smart Drug Delivery Systems for Rheumatoid Arthritis.
    Singh R; Jadhav K; Vaghasiya K; Ray E; Shukla R; Verma RK
    Curr Pharm Des; 2023; 29(13):984-1001. PubMed ID: 37038685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in nanocarrier-based drug delivery systems in treatment of rheumatoid arthritis].
    Liang X; Li YL; Bai HT; Zhang QY; Xiao Z; Sun X; Wen WL; Zhang WY; Yang J; Wang R
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):4874-4883. PubMed ID: 37802829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in nanomedicines for the treatment of rheumatoid arthritis.
    Wang Q; Sun X
    Biomater Sci; 2017 Jul; 5(8):1407-1420. PubMed ID: 28631779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotherapeutic approaches for the treatment of rheumatoid arthritis.
    Pham CT
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(6):607-19. PubMed ID: 21837725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine for the Treatment of Rheumatoid Arthritis.
    Jeong M; Park JH
    Mol Pharm; 2021 Feb; 18(2):539-549. PubMed ID: 32502346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine is more than a supporting role in rheumatoid arthritis therapy.
    Han Y; Huang S
    J Control Release; 2023 Apr; 356():142-161. PubMed ID: 36863691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of nanoparticle technology in the treatment of Systemic lupus erythematous.
    Rostamzadeh D; Razavi SR; Esmaeili S; Dolati S; Ahmahi M; Sadreddini S; Jadidi-Niaragh F; Yousefi M
    Biomed Pharmacother; 2016 Oct; 83():1154-1163. PubMed ID: 27551763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationalized Insights on Causes of Rheumatoid Arthritis in the Elderly and Women: Special Emphasis on Treatment Strategies.
    Srivastava S; Patel S; Singh D; Singh MR
    Crit Rev Ther Drug Carrier Syst; 2017; 34(2):97-147. PubMed ID: 28605317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Biologic Nanodelivery Therapies for Rheumatoid Arthritis.
    Gouveia VM; Lima SA; Nunes C; Reis S
    J Biomed Nanotechnol; 2015 Oct; 11(10):1701-21. PubMed ID: 26502635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-platform Strategies of Herbal Components for the Management of Rheumatoid Arthritis: A Review on the Battle for Next-Generation Formulations.
    Prabha J; Kumar M; Kumar D; Chopra S; Bhatia A
    Curr Drug Deliv; 2024; 21(8):1082-1105. PubMed ID: 37622715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancement in contemporary diagnostic and therapeutic approaches for rheumatoid arthritis.
    Kumar LD; Karthik R; Gayathri N; Sivasudha T
    Biomed Pharmacother; 2016 Apr; 79():52-61. PubMed ID: 27044812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Delivery System Approaches for Rheumatoid Arthritis Treatment: A Review.
    Garhwal A; Kendya P; Soni S; Kori S; Soni V; Kashaw SK
    Mini Rev Med Chem; 2024; 24(7):704-720. PubMed ID: 37711105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overview.
    Thakur S; Riyaz B; Patil A; Kaur A; Kapoor B; Mishra V
    Biomed Pharmacother; 2018 Oct; 106():1011-1023. PubMed ID: 30119166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.